GamaMabs Pharma
Business Services · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
60 Avenue Charles De Gaulle, Neuilly-sur...Phone Number
+33 664126631Website
www.gamamabs.comRevenue
$7.8 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About GamaMabs Pharma
GamaMabs Pharma, a French immuno-oncology biotechnology company, is a leader in the development of optimized antibodies targeting AMHR2 for the treatment of cancer. GamaMabs' first-in-class proprietary therapeutic monoclonal antibodies have the potential for broad applications in cancer. The company develops low-fucose EMABling® antibodies (license granted by LFB) with increased tumor cell killing properties through a breakthrough activation of immune cells.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GamaMabs Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at GamaMabs Pharma
Earning: See what the market has to say on GamaMabs Pharma recently announced quarterly report
Funding: Get notified immidiatlly once GamaMabs Pharma has new funding data
Click to see if GamaMabs Pharma had a recent Job posting/layoffs
GamaMabs Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when GamaMabs Pharma launches new products
Check if GamaMabs Pharma has recently received funding, and reach out quickly before it becomes old news!
Check out if GamaMabs Pharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined GamaMabs Pharma as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
GamaMabs Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
GamaMabs Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about GamaMabs Pharma.
GamaMabs Pharma financials insights
Gather financial insights about GamaMabs Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Series A
$5.7M
2015
Series B
$16.6M
GamaMabs Pharma Tech Stack
A closer look at the technologies used by GamaMabs Pharma
GamaMabs Pharma News & Media
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding GamaMabs Pharma
Sign Up For FreeTo access detailed company insights
GamaMabs Pharma, a French immuno-oncology biotechnology company, is a leader in the development of optimized antibodies targeting AMHR2 for the treatment of cancer. GamaMabs' first-in-class proprietary therapeutic monoclonal antibodies have the potential for broad applications in cancer. The company develops low-fucose EMABling® antibodies (license... Read More
